InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong · Delayed Price · Currency is HKD
64.30
-1.10 (-1.68%)
At close: May 8, 2026
HKG:3696 Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| -352.32 | -17.1 | -211.64 | -221.83 |
Depreciation & Amortization | 4.77 | 6.05 | 4.48 | 1.78 |
| 1.68 | - | - | - |
Loss (Gain) From Sale of Assets | 0.13 | - | 0.01 | 2.19 |
Loss (Gain) From Sale of Investments | 294.4 | -9.56 | -0.45 | 1.04 |
| 6.51 | 3.26 | 10.79 | 12.92 |
Provision & Write-off of Bad Debts | 0.71 | -0.01 | -0.16 | 0.23 |
Other Operating Activities | -5.08 | -6.9 | 122.23 | 138.53 |
Change in Accounts Receivable | -19.84 | 2.86 | 2.11 | -5.95 |
Change in Accounts Payable | -1.25 | 0.29 | 9.14 | 12.69 |
Change in Unearned Revenue | -4.77 | -35.56 | 37.43 | 5.03 |
Change in Other Net Operating Assets | -1.72 | -0.73 | -3.52 | 5.84 |
| -76.77 | -57.4 | -29.58 | -47.52 |
| -2.86 | -0.84 | -2.56 | -10.98 |
Sale of Property, Plant & Equipment | - | - | 0.01 | - |
| - | - | - | -2.22 |
Sale (Purchase) of Intangibles | -0.12 | -0.08 | -0.41 | -0.24 |
| -53.23 | - | - | - |
Other Investing Activities | 5.91 | 8.35 | 3.66 | -0.15 |
| -50.3 | 7.42 | 0.69 | -13.58 |
| -2.08 | -1.56 | -1.4 | -0.97 |
| -2.08 | -1.56 | -1.4 | -0.97 |
| 275.4 | 0.41 | 0.01 | 0.21 |
Other Financing Activities | -0.67 | -0.38 | -0.79 | -1.83 |
| 393.74 | -1.54 | -2.18 | 107.15 |
Foreign Exchange Rate Adjustments | 0.71 | 0.28 | 0.37 | 0.29 |
| 267.4 | -51.24 | -30.7 | 46.34 |
| -79.62 | -58.25 | -32.14 | -58.5 |
| -141.58% | -67.86% | -62.79% | -194.03% |
| -1.01 | -0.81 | -0.48 | -0.87 |
| 0.21 | 0.09 | 0.09 | 0.1 |
| -820.54 | -56.4 | 128.96 | - |
| -820.41 | -56.34 | 129.02 | - |
Change in Working Capital | -27.57 | -33.14 | 45.16 | 17.62 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.